NIIMBL eXperience Program Provides Students Glimpse聽into the Biopharmaceutical Field
The Stack Family Center for Biopharmaceutical Education and Training (CBET) at 糖心vlog will host a cohort of 11 undergraduates to provide them with a view into the world of biotherapeutics. The NIIMBL eXperience, scheduled for June 2-8, 2024, is designed to tell the story of biopharmaceuticals from discovery to patient delivery to a聽cohort of diverse students.
This year鈥檚 cohort includes students from a variety of colleges and universities includes:
- Tomisin Adebari, Morgan State University
- Aniyah Allen, University at Albany
- Ezekiel Ekanem, Vassar College
- Katrina Hampton, University at Albany
- Emily Louie, 糖心vlog
- Zoe Migioni, Johnson C. Smith University
- Joy Mwangangye, Massbay Community College
- Pristine Onuoha, University of North Carolina at Chapel Hill
- Arreyelle Wilson, Morgan State University
- Kai Young, Xavier University of Louisiana
- Grace Zhao, Brooklyn College
Dancan Oruko 鈥�26, an ACPHS student, participated in CBET鈥檚 first NIIMBL eXperience in 2023. , 鈥淚t was a very in-depth exploration from the R&D of a drug all the way to someone now being able to consume the drug.鈥�
The NIIMBL eXperience at CBET
Get a glimpse into
The College鈥檚聽Stack Center for Biopharmaceutical Education and Training (CBET)聽in conjunction with聽,听,听,听,听,听,听, and University at Albany聽听补苍诲听,听will host an array of programming designed to illustrate the broad spectrum of career paths available within the biopharma industry.
During this weeklong session, the students will:
- Explore the discovery, biomanufacturing and delivery of therapies including antibody, cell, gene, and mRNA technologies
- Learn via hands-on activities in fermentation, nanoparticle formation and flow cytometry
- Discuss and view RNA computer simulations while touring a COVID-testing laboratory
- Tour three local small businesses that highlight innovation and entrepreneurship in the biopharma industry
As the week progresses, students will visit development and manufacturing sites to witness scale-up and cGMP processes and discuss the complex process of manufacturing lipids for vaccines and therapies as well as state-of-the-art synthetic platforms for antibody drug-conjugates, cell-based therapies for regenerative medicine and medical devices for drug delivery.聽Participants will compound a drug to make an infusion bag, deliver immunizations and patient counseling.
In addition, ACPHS will host peer and professional networking events with diversity discussion panels. Students will have an opportunity聽to build individualized branding plans and participate in a 360-degree feedback session to help identify career pathways utilizing the network of resources discovered during this NIIMBL eXperience.
鈥淏y convening ACPHS鈥� regional strengths and bringing together current biopharma students and industry professionals, participants engage in a career support network that ensures continued mentoring and success,鈥� said Michelle Lewis, executive director, CBET. 鈥淭his program provides an excellent opportunity for diverse students to find pathways into this emerging career field.鈥�
NIIMBL is a public-private partnership with the goal of advancing innovation in biopharmaceutical manufacturing. NIIMBL is part of Manufacturing USA庐, a network of 17 manufacturing institutes across the country that brings together industry, academia, and the public sector to propel promising research and technology developments, accelerate new products to market, and train tomorrow鈥檚 workforce in order to secure America鈥檚 future. NIIMBL is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce, and leverages additional support from industry, academic institutions, non-profit organizations, and several state governments. The NIIMBL mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry.
This work is performed under financial assistance award #70NANB21H086 from the U.S. Department of Commerce, National Institute of Standards and Technology.
础产辞耻迟听颁叠贰罢
Stack Family Center for Biopharmaceutical Education and Training (CBET) is ACPHS鈥� response to the rapidly growing biopharmaceutical field and the need for an educated workforce, which has been cited as one of the critical constraints to growth of the biopharmaceutical industry. The Center will provide students with the knowledge and hands-on experience to bring innovative biopharmaceuticals to patients. CBET is the first training facility in the nation to be created by a pharmacy college.
Social